Vaginal tablet for treating lower back pain, abdominal pain, hemostasis in threatened abortion, female infertility, pain during menstruation, premenstrual syndrome (PMS), endometriosis, heavy menstrual bleeding, and preeclampsia, comprises dydrogesterone or its salts or esters, and excipients
2023-10-04
专利权人MANKIND PHARMA LTD (MANK-Non-standard)
申请日期2023-10-04
专利号IN202311066520-A
成果简介NOVELTY - A vaginal tablet comprises 5-40 mg dydrogesterone or its salts or esters, and excipients. USE - Vaginal tablet for treating lower back pain, abdominal pain, hemostasis in threatened abortion, female infertility, pain during menstruation, premenstrual syndrome (PMS), endometriosis, heavy menstrual bleeding, and preeclampsia, and treating irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. No biological data given. ADVANTAGE - The vaginal tablet has improved patient compliance, and is convenient to apply or insert without the need of special auxiliary appliances with less uncomfortableness, and the medicine does not spill out of vagina, and can be prepared in simple and cost-effective manner.
IPC 分类号A61K-031/567 ; A61K-031/568 ; A61K-031/57 ; A61K-047/10 ; A61K-009/06
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20136
专题中国科学院新疆生态与地理研究所
作者单位
MANKIND PHARMA LTD (MANK-Non-standard)
推荐引用方式
GB/T 7714
KUMAR A,MUTHULINGAM C,KARTHIKEYAN V,et al. Vaginal tablet for treating lower back pain, abdominal pain, hemostasis in threatened abortion, female infertility, pain during menstruation, premenstrual syndrome (PMS), endometriosis, heavy menstrual bleeding, and preeclampsia, comprises dydrogesterone or its salts or esters, and excipients. IN202311066520-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。